Results 1 to 10 of about 14,441,511 (335)

Label-free enrichment of rare unconventional circulating neoplastic cells using a microfluidic dielectrophoretic sorting device

open access: yesCommunications Biology, 2021
Montoya Mira & Sapre et al. design a microfluidic device utilizing dielectrophoresis for the enrichment of circulating neoplastic cells that possess both epithelial and immune-like characteristics. They optimized the device using in vitro models and then
Jose Montoya Mira   +9 more
doaj   +1 more source

SAR-BagNet: An Ante-hoc Interpretable Recognition Model Based on Deep Network for SAR Image

open access: yesRemote Sensing, 2022
Convolutional neural networks (CNNs) have been widely used in SAR image recognition and have achieved high recognition accuracy on some public datasets. However, due to the opacity of the decision-making mechanism, the reliability and credibility of CNNs
Peng Li   +3 more
doaj   +1 more source

Epigenetic loss of heterogeneity from low to high grade localized prostate tumours

open access: yesNature Communications, 2021
High tumour heterogeneity hinders the identification of molecular subtypes in prostate cancer. Here, the authors integrate single-cell chromatin accessibility data with multiplex imaging and reveal distinct chromatin features and transcriptional factor ...
Sebnem Ece Eksi   +7 more
doaj   +1 more source

Early detection: introduction [PDF]

open access: yesEuropean Respiratory Journal, 2003
The present Supplement of the European Respiratory Journal assembles a number of reviews on “Early detection” and it is the product of a symposium held in Barcelona on June 22 2002. The symposium was organised by the European Institute of Healthcare, which was set up by AstraZeneca.
M, Decramer, C, Roussos
openaire   +2 more sources

Turning antibodies off and on again using a covalently tethered blocking peptide

open access: yesCommunications Biology, 2022
Modulation of antibody binding is developed through a photo-cleavable tether that is covalently conjugated to the antibody and to a blocking peptide.
Michael Brasino   +7 more
doaj   +1 more source

Selective enrichment of plasma cell-free messenger RNA in cancer-associated extracellular vesicles

open access: yesCommunications Biology, 2023
Extracellular vesicles (EVs) have been shown as key mediators of extracellular small RNA transport. However, carriers of cell-free messenger RNA (cf-mRNA) in human biofluids and their association with cancer remain poorly understood. Here, we performed a
Hyun Ji Kim   +12 more
doaj   +1 more source

Hybrid Silica-Coated PLGA Nanoparticles for Enhanced Enzyme-Based Therapeutics

open access: yesPharmaceutics, 2022
Some cancer cells rely heavily on non-essential biomolecules for survival, growth, and proliferation. Enzyme based therapeutics can eliminate these biomolecules, thus specifically targeting neoplastic cells; however, enzyme therapeutics are susceptible ...
Kyle T. Gustafson   +8 more
doaj   +1 more source

Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies

open access: yesnpj Precision Oncology, 2022
Cell-free RNA (cfRNA) in plasma reflects phenotypic alterations of both localized sites of cancer and the systemic host response. Here we report that cfRNA sequencing enables the discovery of messenger RNA (mRNA) biomarkers in plasma with the tissue of ...
Breeshey Roskams-Hieter   +12 more
doaj   +1 more source

Imaging of HER2 detected receptor expression positive breast cancer: from detection to interpretation

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2023
Background Aggressive invasion, high recurrence rate, and poor prognosis are common features of the human epidermal growth factor receptor-2 (HER2)-enriched breast cancer, yet on the other side, it shows significantly reduced activity in response to ...
Sahar Mansour   +3 more
doaj   +1 more source

Oncogene-mediated metabolic gene signature predicts breast cancer outcome

open access: yesnpj Breast Cancer, 2021
Breast cancer remains the second most lethal cancer among women in the United States and triple-negative breast cancer is the most aggressive subtype with limited treatment options.
Merve Aslan   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy